Illumina Inc.

AI Score

0

Unlock

136.28
-7.94 (-5.51%)
At close: Jan 14, 2025, 3:59 PM
139.75
2.55%
After-hours Jan 14, 2025, 05:19 PM EST
undefined%
Bid 136.72
Market Cap 21.61B
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -9.97
PE Ratio (ttm) -13.67
Forward PE n/a
Analyst Hold
Ask 139.02
Volume 2,624,105
Avg. Volume (20D) 1,990,595
Open 145.25
Previous Close 144.22
Day's Range 136.26 - 153.06
52-Week Range 97.36 - 156.66
Beta undefined

About ILMN

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequenci...

Sector Healthcare
IPO Date Jul 28, 2000
Employees 10,590
Stock Exchange NASDAQ
Ticker Symbol ILMN

Analyst Forecast

According to 17 analyst ratings, the average rating for ILMN stock is "Hold." The 12-month stock price forecast is $152, which is an increase of 11.54% from the latest price.

Buy 52.94%
Hold 47.06%
Sell 0.00%
Stock Forecasts

Next Earnings Release

Illumina Inc. is scheduled to release its earnings on Feb 6, 2025, after market closes.
Analysts project revenue of $1.07B, reflecting a -4.63% YoY shrinking and earnings per share of 0.92, making a 557.14% increase YoY.
5 months ago · Source
+2.14%
Illumina shares are trading higher after Barclays ... Unlock content with Pro Subscription
5 months ago · Source
-3.87%
Illumina shares are trading lower amid the company's outlook at its investor presentation.